Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
Common Stock
Bristol-Myers Squibb Co
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bristol-Myers Squibb Co
NYSE:BMY
|
Common Stock
$292m
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Johnson & Johnson
NYSE:JNJ
|
Common Stock
$3.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Pfizer Inc
NYSE:PFE
|
Common Stock
$478m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Merck & Co Inc
NYSE:MRK
|
Common Stock
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Zoetis Inc
NYSE:ZTS
|
Common Stock
$5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Common Stock
$594.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
See Also
What is Bristol-Myers Squibb Co's Common Stock?
Common Stock
292m
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Common Stock amounts to 292m USD.
What is Bristol-Myers Squibb Co's Common Stock growth rate?
Common Stock CAGR 10Y
3%
Over the last year, the Common Stock growth was 0%.